Tennessee Oncology;Chattanooga Oncology & Hematology Associates

Chattanooga, Tennessee 37404-1130

1 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, Follicular Lymphoma, Metastatic Breast Cancer, Part 1：r/r B-cell Malignancies, Part 2：B-cell Malignancies

Studies at this site

• A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer — Recruiting now
• A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab + Lenalidomide (+Len), and the Safety, Tolerability, and Pharmacokinetics of SC Versus IV Mosunetuzumab + Len in Participants With Follicular Lymphoma — Running, not enrolling
• A Study of Tyrosine Kinase Inhibitor Orelabrutinib (ICP-022) in Patients With r/r B-Cell Malignancies — Running, not enrolling
• Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC) — Completed